Institution
Goethe University Frankfurt
Education•Frankfurt am Main, Hessen, Germany•
About: Goethe University Frankfurt is a education organization based out in Frankfurt am Main, Hessen, Germany. It is known for research contribution in the topics: Population & Transplantation. The organization has 33342 authors who have published 69743 publications receiving 2409538 citations. The organization is also known as: Johann Wolfgang Goethe-Universität Frankfurt am Main & University of Frankfurt am Main.
Papers published on a yearly basis
Papers
More filters
••
University of Genoa1, University of Manchester2, KEK3, CERN4, Imperial College London5, Stanford University6, Tata Institute of Fundamental Research7, Istituto Nazionale di Fisica Nucleare8, University of Pittsburgh9, Lyon College10, TRIUMF11, Northeastern University12, Thomas Jefferson National Accelerator Facility13, University of Córdoba (Spain)14, Goethe University Frankfurt15, University of Southampton16, University of Udine17, University of Alberta18, Tokyo Metropolitan University19, Helsinki Institute of Physics20, National Research Nuclear University MEPhI21, University of Bath22, Niigata University23, Naruto University of Education24, Kobe University25, University of Calabria26, University of Trieste27, European Space Agency28, University of Birmingham29, Ritsumeikan University30, Qinetiq31, École Polytechnique Fédérale de Lausanne32, Massachusetts Institute of Technology33, Brookhaven National Laboratory34
01 Jul 2003-Nuclear Instruments & Methods in Physics Research Section A-accelerators Spectrometers Detectors and Associated Equipment
TL;DR: The Gelfant 4 toolkit as discussed by the authors is a toolkit for simulating the passage of particles through matter, including a complete range of functionality including tracking, geometry, physics models and hits.
Abstract: G eant 4 is a toolkit for simulating the passage of particles through matter. It includes a complete range of functionality including tracking, geometry, physics models and hits. The physics processes offered cover a comprehensive range, including electromagnetic, hadronic and optical processes, a large set of long-lived particles, materials and elements, over a wide energy range starting, in some cases, from 250 eV and extending in others to the TeV energy range. It has been designed and constructed to expose the physics models utilised, to handle complex geometries, and to enable its easy adaptation for optimal use in different sets of applications. The toolkit is the result of a worldwide collaboration of physicists and software engineers. It has been created exploiting software engineering and object-oriented technology and implemented in the C++ programming language. It has been used in applications in particle physics, nuclear physics, accelerator design, space engineering and medical physics.
18,904 citations
••
University of Barcelona1, University of Pisa2, University of Duisburg-Essen3, Auckland City Hospital4, University of São Paulo5, European University6, Icahn School of Medicine at Mount Sinai7, Goethe University Frankfurt8, University of Bologna9, Hannover Medical School10, University of Mainz11, Aix-Marseille University12, Université catholique de Louvain13, University of Düsseldorf14, Bayer15, Bayer Corporation16
TL;DR: In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than for those given placebo.
Abstract: Background No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma. Methods In this multicenter, phase 3, double-blind, placebo-controlled trial, we randomly assigned 602 patients with advanced hepatocellular carcinoma who had not received previous systemic treatment to receive either sorafenib (at a dose of 400 mg twice daily) or placebo. Primary outcomes were overall survival and the time to symptomatic progression. Secondary outcomes included the time to radiologic progression and safety. Results At the second planned interim analysis, 321 deaths had occurred, and the study was stopped. Median overall survival was 10.7 months in the sorafenib group and 7.9 months in the placebo group (hazard ratio in the sorafenib group, 0.69; 95% confidence interval, 0.55 to 0.87; P<0.001). There was no significant difference between the two groups in the median time to symptomatic progression (4.1 months vs. 4.9 months, respectively, P=0.77). The median time to radiologic progression was 5.5 months in the sorafenib group and 2.8 months in the placebo group (P<0.001). Seven patients in the sorafenib group (2%) and two patients in the placebo group (1%) had a partial response; no patients had a complete response. Diarrhea, weight loss, hand-foot skin reaction, and hypophosphatemia were more frequent in the sorafenib group. Conclusions In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than for those given placebo.
10,074 citations
••
TL;DR: This study traces the course of the pathology in incidental and symptomatic Parkinson cases proposing a staging procedure based upon the readily recognizable topographical extent of the lesions.
8,452 citations
••
TL;DR: The development, current features, and some directions for future development of the Amber package of computer programs, which contains a group of programs embodying a number of powerful tools of modern computational chemistry, focused on molecular dynamics and free energy calculations of proteins, nucleic acids, and carbohydrates.
Abstract: We describe the development, current features, and some directions for future development of the Amber package of computer programs. This package evolved from a program that was constructed in the late 1970s to do Assisted Model Building with Energy Refinement, and now contains a group of programs embodying a number of powerful tools of modern computational chemistry, focused on molecular dynamics and free energy calculations of proteins, nucleic acids, and carbohydrates.
7,672 citations
••
TL;DR: The authors show the double-slit interference effect in the strong-field ionization of neon dimers by employing COLTRIMS method to record the momentum distribution of the photoelectrons in the molecular frame.
Abstract: Wave-particle duality is an inherent peculiarity of the quantum world. The double-slit experiment has been frequently used for understanding different aspects of this fundamental concept. The occurrence of interference rests on the lack of which-way information and on the absence of decoherence mechanisms, which could scramble the wave fronts. Here, we report on the observation of two-center interference in the molecular-frame photoelectron momentum distribution upon ionization of the neon dimer by a strong laser field. Postselection of ions, which are measured in coincidence with electrons, allows choosing the symmetry of the residual ion, leading to observation of both, gerade and ungerade, types of interference.
7,160 citations
Authors
Showing all 33782 results
Name | H-index | Papers | Citations |
---|---|---|---|
Jorge E. Cortes | 163 | 2784 | 124154 |
Marc W. Kirschner | 162 | 457 | 102145 |
Klaus Rajewsky | 154 | 504 | 88793 |
Andreas Pfeiffer | 149 | 1756 | 131080 |
Stefanie Dimmeler | 147 | 574 | 81658 |
Hans Peter Beck | 143 | 1134 | 91858 |
Gunther Roland | 141 | 1471 | 100681 |
Ad Bax | 138 | 486 | 97112 |
David G. Harrison | 137 | 492 | 72190 |
Paul Brennan | 132 | 1221 | 72748 |
Andreas M. Zeiher | 129 | 571 | 75125 |
Jürgen Habermas | 126 | 503 | 114175 |
Vincenzo Di Marzo | 126 | 659 | 60240 |
Stuart J. Connolly | 125 | 610 | 75925 |
James D. Griffin | 124 | 490 | 55565 |